Cefalexin Monohydrate Sina et cum officinas artifices | Tecsun

Cefalexin Monohydrate

Description:

Product details are as follows:   Product Name Cefalexin Monohydrate Powder Molecular Formula C16H17N3O4S·H2O Product use Verterinary medicine raw materials Character of product White, crystalline powder Packing 20g/Drum PH 4.0~5.5 Related Substances ≤1% Water 4.0%~8.0% Specific Optical Rotation ( anhydrous substance ) +149°~+158° Sulphated Ash ≤0.2%   Structural formula:   The product is slightly soluble in water but insoluble in ethanol, chloroform or...


Product Detail

Product Tags

Product Details ita se habet:
 
Product # Pulvis Cefalexin Monohydrate
Molecular Formula C 16h 17N 3o 4S · C 2o
Product usu Et rudis materiae medicina Verterinary
Character of uber Alba, crystallinum pulveris
stipare 20g / Gothic
PH 4.0 5.5 ~
Related Corpora ≤1%
aqua ~ 4.0% 8.0%
Imprimis Gallium
rotationis
(anhydrous substantia)
CXLIX ° ~ ° + + CLVIII
Feria Sulphated ≤0.2%

 
Sistens descriptiones  formulam manifestatur:
CAS 23325-78-2 Cefalexin Monohydrate et powder GMP veterinarii API

 

Quod productum est cum ignominia non posse dissolvi in ​​aqua solutum in ethanol praeservatum, chloroform aut aethere.

Lato spectro antibiotics. Maxime utiles et perniciosas, propter gram bacterial Infectiones, ut, amnis c Ommon nuncupatur frigus, septicemia hemorrhagic, streptococcal morbum vero sacro igni piggii, anthrax, EMPHYSEMA, malignántium OEDEMA, Carnificatio,
necrobacillosis, etc.
Item solebat tractare, a varietate morborum inflammatoriorum sicut, p infectious aphragmaticus
EPIDERMIDIS, pneumococcal pneumonia, atrophic RHINITIS, aurem morbus hyacintho, MASTITIS, hysteritis, stomatitis, urethritis c aeuitatem suspiriosis et fecit ex inflammatione agnoscebatur.

Et hoc necessarium productum ne lumen, siccum, obsignatorum repono in a frigus et tenebris locus.

Hoc productum est non-periculo.

Enumerantur sequitur quod alia sunt nostri products,

CAS 23325-78-2 Cefalexin Monohydrate et powder GMP veterinarii API

 


  • Suspendisse
  • Next:

  • Dimitte nobis scribere Read more